BML-278 is a SIRT1 activator (EC150: 1 µM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2].
Molekulargewicht:
391.46
Reinheit:
98.49
CAS Nummer:
[120533-76-8]
Formel:
C24H25NO4
Target-Kategorie:
Histone Methyltransferase,Sirtuin
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten